Business Segments Exelixis, Inc.

Stocks

EXEL

US30161Q1040

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:01 2026-09-18 EDT			5-day change	1st Jan Change
58.36 ^USD	-0.22%		+3.99%	+33.15%

09-15	Exelixis, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 11:30 AM
09-11	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Amid Inflation Data Release	MT

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Geographical Revenue Distribution History

Breakdown by Business Segment (USD)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Biological Products
Discovery, Development & Commercialization of New Medicines for Difficult-To-Treat Cancers						1.43B	1.61B	1.83B	2.17B	2.32B
Total Assets						2.62B	3.07B	2.94B	2.95B	2.84B
Interest Expense						-	-	-	-	-
Income Tax Expense						63.09M	52.07M	49.76M	160M	159M
CAPEX						-64.22M	-27.71M	-40.47M	-28.44M	-8.43M
EBT						294M	234M	258M	682M	941M
D&A						13.63M	20.88M	25.72M	28.8M	29.06M
Operating Income						287M	201M	171M	605M	872M
Net Income						231M	182M	208M	521M	783M

Geographical breakdown of sales (USD)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
United States (U.S.)						1.09B	1.41B	1.65B	1.82B	2.14B
Total Assets						2.62B	3.07B	2.94B	2.95B	2.84B
						-	-	-	-	154M
Europe						302M	169M	145M	319M	154M
Japan						43.5M	28.73M	39.49M	27.08M	25.59M
Rest of The World						-	-	-	-	-
						-	-	-	-	25.59M
						-	-	-	-	2.14B

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!